Tag Archives: Bipolar

European public-private project to advance precision psychiatry by introducing biology into clinical routine

PARIS AND MONTPELLIER, 30-Mar-2022 — /EPR HEALTHCARE NEWS/ — ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health). This newly formed European public-private partnership aims at advancing precision psychiatry by introducing biology into clinical routine.

Around 300M people in the world are affected by depression. Studies show that up to 40% of them may be misdiagnosed and potentially bipolar. As a result, diagnosis is often delayed by an average of 7.5 years, worsening patients’ mental and physical conditions as well as their loved ones’ quality of life.

The EDIT-B Consortium aims to solve this diagnostic challenge by using specific RNA editing based biomarkers and artificial intelligence to validate and commercialize an accurate, reliable, and quick blood test to diagnose bipolar disorder.

The Consortium brings together prominent members from across Europe who will be working over the next three years to achieve this goal: Alcediag, Alcen, Capital Region of Denmark, Fundació Clinic per la Recerca Biomèdica, Fundació Sant Joan de Déu, GHU Paris Psychiatrie & Neurosciences, Hospital Clínic de Barcelona, Parc Sanitari Sant Joan de Déu, ProductLife Group and Synlab. With a total budget of € 5.2 million, EDIT-B is co-funded by the EIT Health (€ 2.5M) and the partners.

“This project will accurately separate bipolar disorder from unipolar disorder. This distinction is extremely important clinically, because the treatments are different. EDIT-B Consortium gathers all relevant expertise and as the principal investigator in the clinical trial, I hope we will be able to validate a test that will improve the lives of many people living with bipolar disorder”, says Prof. Eduard Vieta from the Hospital Clínic de Barcelona.

SYNLAB is the first diagnostic service provider in Europe, present in 36 countries in 4 continents and committed to developing high value solutions for patients  focusing on medical excellence and customer centricity.

Maurizio Ferrari, SYNLAB Italy Chief Medical Officer says: “innovation in healthcare is a key pillar for the customer centricity and  we are very proud to be part of this European research project that really may help patients with psychiatric disorders”.

“I am proud to see that the EDIT-B consortium led by our partner Alcediag – a subsidiary of Alcen – will tackle the challenge of improving the diagnosis of bipolar disorder. In doing so, they support EIT Health main mission which is to help citizens live healthier and longer lives and at the same time put the spotlight on mental health which is key to the proper care management and wellbeing of our communities”, adds Jean Marc Bourez, interim CEO of EIT Health.

“On this World Bipolar Day, Alcediag team is happy to announce its contribution to solving the bipolar disorder diagnostic issue.  We are proud and grateful to our partners and the EIT Health for this opportunity to advance science while having a positive impact on people’s lives”, said Alexandra Prieux, CEO of Alcediag.

SOURCE: EuropaWire

When Depression Gets the Best of You Private Treatment Is Needed

Sunset Malibu, an exclusive treatment center on the California coast, has long been a transformational force in the field of rehabilitation and recovery. Now, Sunset is announcing its redoubled efforts in the fight against clinical depression.

Depression is a disease, not a choice. Depression victims don’t decide to be sick. By the same token, they can’t simply decide to get better. On the contrary, meaningful depression recovery can only occur under the supervision of qualified depression treatment specialists. In the end, there’s no other way for healing to happen, whether it’s Bipolar disorder or severe depression.

That emphasis on professional help is at the heart of Sunset Malibu’s treatment philosophy.

With its world-class caregivers and elegant accommodations, Sunset Malibu is an unparalleled recovery destination. The center has always catered to upscale residents from every corner of the globe. Now Sunset is renewing its commitment to its core values, with the goal of delivering physiological and psychological therapy to depression victims. At Sunset Malibu, the client’s needs always come first.

“Depression is an awful disease,” said Sunset Malibu owner Richard Taite. “But effective depression treatment really can solve the problem. Our mission at Sunset Malibu is to change the lives of the clients who trust us with their health.”

That passion is precisely what sets Sunset apart from its competitors.

Many addiction treatment facilities offer depression treatment programs. However, very few of them devote adequate resources to their depression recovery efforts. Indeed, many people feel that most of the highest-priced rehab centers in California provide their depression treatment clients with woefully insufficient care. As a result, these clients rarely achieve lasting wellness.

Taite asserts that such an inferior standard of service is absolutely unacceptable.

“Our clients look to us as their last best hope for healing,” Taite said. “We at Sunset Malibu, we take that responsibility with all due seriousness. We do everything in our power to ensure positive treatment outcomes for each and every one of our residents. Anything less would be a breach of our professional and personal obligations.”

Depression victims don’t need to be told about the perils of the disease. The good news is that Sunset Malibu has a long record of healing minds and changing lives. For Sunset’s clients and their families, it’s hard to imagine that any selling point could ever possibly be more persuasive than that one.

As with all co-occurring disorders, Sunset Malibu treats Major Depression disorders as a co-occurring disorder with drug and or alcohol abuse. Sunset Malibu is a luxury Depression and Anxiety treatment center located in Malibu, California. For further details about Sunset’s treatment strategies, accommodations, or other general facts, please call 1-800-332-9202 or visit our Web site at http://www.drugrehabsunsetmalibu.com/.

Via EPR Network
More Healthcare press releases